Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2009
11/11/2009CN100558368C Method and material for treating immune diseases
11/11/2009CN100558346C Chinese medicinal preparation for statis moving hemostatis, swell dispersing pain stopping and its preparation method
11/10/2009US7615611 Human cytokine receptor
11/10/2009US7615576 Prevention of neutrophil recruitment
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009US7615341 Using allelic mutation on human chromosome 8 as diagnostic indicator of degenerative joint disease
11/10/2009US7615237 Percutaneously absorbable preparations
11/10/2009US7615207 Methods for treating irritable bowel syndrome
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2335914C Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
11/05/2009WO2009134962A2 Claudin-4 binding peptides, compositions and methods of use
11/05/2009WO2009134917A2 Methods for treating inflammation
11/05/2009WO2009134389A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133692A1 Quinoline compound
11/05/2009WO2009133647A1 Polymerized cyclic nitroxide radical compound, and use thereof
11/05/2009WO2009133637A1 Sheet preparation for external use and sheet preparation set for external use
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009133136A1 Compounds
11/05/2009WO2009133135A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009WO2009133103A1 Inhibitors of gm-csf and il-17 for therapy
11/05/2009WO2009132454A1 Di-t-butylphenyl piperazines as calcium channel blockers
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009WO2009108720A3 Antagonists of prostaglandin d2 receptors
11/05/2009WO2009099840A3 Methods of manufacture of morinda citrifolia based compositions for treatment of anti-inflammatory diseases through inhibition of cox-1, cox-2, interleukin-1beta, interleukin-6, tnf-alpha, hle, and inos
11/05/2009WO2009071855A3 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition
11/05/2009US20090275738 Use of A33 antigens and jam-it
11/05/2009US20090275656 Medicinal Compositions of Salts, Chelates and/or Free Acids of Alpha Hydroxyl Organic Acids and Related Processes and Methods
11/05/2009US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
11/05/2009US20090275634 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275498 Novel peptides
11/05/2009US20090274730 Compositions and methods for treating inflammation
11/05/2009US20090274721 Compositions Comprising Hypsizygus Ulmarius Extract
11/05/2009US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009US20090274696 Methods for treating inflammation
11/05/2009US20090274688 Antibodies to OPGL
11/05/2009US20090274680 Human Phospholipases
11/05/2009US20090274661 Use of bifidobacterium longum for the prevention and treatment of inflammation
11/05/2009CA2723118A1 Polymerized cyclic nitroxide radical compound and use thereof
11/05/2009CA2723062A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009CA2722706A1 Di-t-butylphenyl piperazines as calcium channel blockers
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722668A1 Methods for treating inflammation
11/05/2009CA2722648A1 Aminopyridine derivatives
11/05/2009CA2717987A1 Inhibitors of gm-csf and il-17 for therapy
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2113252A1 A forsythoside injection and preparation thereof
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009CN101573356A Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/04/2009CN101573131A Anti-connexin compounds and uses thereof
11/04/2009CN101573111A Formulations of phospholipase enzyme inhibitors
11/04/2009CN101570528A Glycyrrhizin derivatives and preparation and use thereof
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/04/2009CN101569682A Medical composition for treating rheumatoid arthritis and preparation method and quality control method thereof
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612113 Hydroxy tetrahydro-naphthalenylurea derivatives
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
11/03/2009US7611730 Containing racemate of tramadol in slow-release form and (+)enantiomer of tramadol in immediate-release form; analgesic efficacy results from interplay of enantiomers by mechanism which includes non-opioid and opiod components
11/03/2009US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009CA2565660C Ortho substituted aryl or heteroaryl amide compounds
11/03/2009CA2447924C Olopatadine formulations for topical administration
11/03/2009CA2424579C Ultraviolet-screening patch
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2372668C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
11/03/2009CA2205379C Yeast-based delivery vehicles
10/2009
10/29/2009WO2009132119A2 Substituted oxazolidinones
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131098A1 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130615A2 Use of deuterium oxide as an elastase inhibitor
10/29/2009WO2009130600A2 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
10/29/2009WO2009130560A1 Fused pyrimidineone compounds as trpv3 modulators
10/29/2009WO2009130310A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009WO2009130242A1 Low molecular weight derivatives and use thereof in treatment of prostaglandin e synthase related diseases
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 1272